ArticleJAMA network open2018
Evaluating the Potential Benefits of Using Sustained Response as a Prognostic Factor in Intermediate Hepatocellular Carcinoma Following Treatment With Conventional Chemoembolization.
Jesse A BerlinPubMed ↗Publisher ↗
No numbers read from the abstract.